ESR1 and breast cancer: Indeed, the SARS-CoV-2 Metagene signature, generated by utilizing the above-mentioned 23 genes, was able to discriminate breast cancer patients with different OS only in the premenopausal luminal A subgroup, suggesting that the coordinated biological functions of these genes may impact breast cancer biology and clinical outcomes only when estrogen receptor signaling is active.